Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8067)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2016 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Waterland P, Athanasiou T, Patel H. Post-operative abdominal complications in Crohn’s disease in the biological era: Systematic review and meta-analysis. World J Gastrointest Surg 2016; 8(3): 274-283 [PMID: 27022455 DOI: 10.4240/wjgs.v8.i3.274] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i3/274.htm |
| Number | Citing Articles |
| 1 |
Marco Ettore Allaix, Andrea Resegotti, Mario Morino. Effects of Preoperative Anti-TNF Therapy on Specimen Length in Crohn’s Disease and Beyond. Journal of Investigative Surgery 2022; 35(6): 1366 doi: 10.1080/08941939.2022.2048143
|
| 2 |
Kevin A. Chen, Valerie Gartner, Kimberly C. Darlington, Sophie R. Silverstein, Meaghan M. Kennedy Ng, Logan Butler, Kelli Avalos, Nina C. Nishiyama, Chinmaya U. Joisa, Matthew R. Schaner, Grace Lian, Caroline Beasley, Gwen W. Lau, Mikaela J. Bauer, Lee-Ching Zhu, Muneera R. Kapadia, Shawn M. Gomez, Terrence S. Furey, Shehzad Z. Sheikh. Post-operative Crohn’s Disease Recurrence and Infectious Complications: A Transcriptomic Analysis. Digestive Diseases and Sciences 2024; doi: 10.1007/s10620-024-08595-3
|
| 3 |
Lillias Holmes Maguire, Karim Alavi, Ranjan Sudan, Paul E. Wise, Andreas M. Kaiser, Liliana Bordeianou. Surgical Considerations in the Treatment of Small Bowel Crohn’s Disease. Journal of Gastrointestinal Surgery 2017; 21(2): 398 doi: 10.1007/s11605-016-3330-9
|
| 4 |
Yang‐Sheng Lin, Sheng‐Wei Cheng, Yuan‐Hung Wang, Kee‐Hsin Chen, Ching‐Ju Fang, Chiehfeng Chen. Systematic review with meta‐analysis: risk of post‐operative complications associated with pre‐operative exposure to anti‐tumour necrosis factor agents for Crohn’s disease. Alimentary Pharmacology & Therapeutics 2019; 49(8): 966 doi: 10.1111/apt.15184
|
| 5 |
Margaret H. Sundel, John J. Newland, Kyle W. Blackburn, Roumen M. Vesselinov, Samuel Eisenstein, Andrea C. Bafford. Sex-Based Differences in Inflammatory Bowel Disease Surgical Outcomes. Diseases of the Colon & Rectum 2023; doi: 10.1097/DCR.0000000000002984
|
| 6 |
Daniel J Wong, Eve M Roth, Joseph D Feuerstein, Vitaliy Y Poylin. Surgery in the age of biologics. Gastroenterology Report 2019; 7(2): 77 doi: 10.1093/gastro/goz004
|
| 7 |
Sara Gaines, Sanjiv Hyoju, Ashley J. Williamson, Jasper B. van Praagh, Olga Zaborina, David T. Rubin, John C. Alverdy, Benjamin D. Shogan, Neil Hyman. Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis. Journal of Gastrointestinal Surgery 2020; 24(11): 2637 doi: 10.1007/s11605-019-04486-5
|
| 8 |
Fabian Schnitzler, Cornelia Tillack-Schreiber, Daniel Szokodi, Isabel Braun, June Tomelden, Maximilian Sohn, Franz Bader, Constanze Waggershauser, Thomas Ochsenkühn, Marco Clementi. Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center. PLOS ONE 2024; 19(1): e0290887 doi: 10.1371/journal.pone.0290887
|
| 9 |
J.W. Baddley, F. Cantini, D. Goletti, J.J. Gómez-Reino, E. Mylonakis, R. San-Juan, M. Fernández-Ruiz, J. Torre-Cisneros. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). Clinical Microbiology and Infection 2018; 24: S10 doi: 10.1016/j.cmi.2017.12.025
|
| 10 |
Dorina Bajzát, Adrienn F Kéri, Marcell Imrei, Tamás Kói, Andrea Párniczky, Péter Hegyi, Kinga Kovács, Szilárd Váncsa, Katalin Eszter Müller. Safety Analysis of Preoperative Anti-TNF-α Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis. Inflammatory Bowel Diseases 2023; 29(12): 1971 doi: 10.1093/ibd/izac274
|
| 11 |
Pär Myrelid, Mattias Soop, Bruce D. George. Surgical Planning in Penetrating Abdominal Crohn's Disease. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.867830
|
| 12 |
Maria M. Crespo, Tamara Claridge, Robyn T. Domsic, Matthew Hartwig, Jasleen Kukreja, Kathleen Stratton, Kevin M. Chan, Maria Molina, Patricia Ging, Adam Cochrane, Konrad Hoetzenecker, Usman Ahmad, Siddhartha Kapnadak, Irina Timofte, Geert Verleden, Dennis Lyu, Sana Quddus, Nicole Davis, Mary Porteous, Jorge Mallea, Michael Perch, Olivier Distler, Kristin Highland, Jesper Magnusson, Robin Vos, Allan R. Glanville. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements. The Journal of Heart and Lung Transplantation 2021; 40(11): 1279 doi: 10.1016/j.healun.2021.07.013
|
| 13 |
C. Shwaartz, A. C. Fields, M. Sobrero, C. M. Divino. Does bowel preparation for inflammatory bowel disease surgery matter?. Colorectal Disease 2017; 19(9): 832 doi: 10.1111/codi.13693
|
| 14 |
Andrea Resegotti, Davide Giuseppe Ribaldone. Is a Protective Stoma Mandatory in Anti–Tumor Necrosis Factor–Treated Crohn’s Disease Patients Undergoing Surgery?. Gastroenterology 2023; 164(2): 307 doi: 10.1053/j.gastro.2022.04.046
|
| 15 |
Yang‐Sheng Lin, Ming‐Jen Chen, Wei‐Chen Lin, Yuan‐Hung Wang, Chiehfeng Chen. Letter: should we delay surgery, or stop anti‐TNF therapy prior to elective surgical procedures in Crohn’s disease patients receiving anti‐TNF agents? Authors’ reply. Alimentary Pharmacology & Therapeutics 2019; 50(8): 970 doi: 10.1111/apt.15487
|
| 16 |
Chun‐Chi Lin, Hung‐Hsin Lin, Hui‐Chuen Chen, Nai‐Chia Chen, I‐Lun Shih, Ji‐Shiang Hung, Te‐Cheng Yueh, Feng‐Fan Chiang, Ping‐Wei Lin, Yuan‐Yao Tsai, Shu‐Chen Wei. Perioperative optimization of Crohn's disease. Annals of Gastroenterological Surgery 2023; 7(1): 10 doi: 10.1002/ags3.12621
|
| 17 |
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen, A Barney Hawthorne. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019; 68(Suppl 3): s1 doi: 10.1136/gutjnl-2019-318484
|
| 18 |
Clayton Tyler Ellis, Justin A. Maykel. Defining Anastomotic Leak and the Clinical Relevance of Leaks. Clinics in Colon and Rectal Surgery 2021; 34(06): 359 doi: 10.1055/s-0041-1735265
|
| 19 |
Cindy CY Law, Conor Bell, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2020; 2021(12) doi: 10.1002/14651858.CD013256.pub2
|
| 20 |
W A Bemelman, Michel Adamina, Christianne Buskens, Andre DHoore, Paulo Gustavo Kotze, Tom Oresland, Yves Panis, Gianluca Samprieto, Antonino Spinelli, Hagit Tulchinsky, Janindra Warusavitarne, Oded Zmora. Evolving Role of IBD Surgery. Journal of Crohn's and Colitis 2018; 12(8): 1005 doi: 10.1093/ecco-jcc/jjy056
|
| 21 |
Chenjing Zhu, Xuelei Ma, Luqi Xue, Jing Xu, Qingfang Li, Yun Wang, Jing Zhang. Small intestine contrast ultrasonography for the detection and assessment of Crohn disease. Medicine 2016; 95(31): e4235 doi: 10.1097/MD.0000000000004235
|
| 22 |
Serena R. Martin, Robert V. Bryant. Inflammatory Bowel Disease Nursing Manual. 2019; : 189 doi: 10.1007/978-3-319-75022-4_21
|
| 23 |
Abel Botelho Quaresma, Takayuki Yamamoto, Paulo Gustavo Kotze. Biologics and surgical outcomes in Crohn’s disease: is there a direct relationship?. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820931738
|
| 24 |
Cindy C Y Law, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 2020; 26(12): 1796 doi: 10.1093/ibd/izaa020
|
| 25 |
Takayuki Yamamoto, Fabio Vieira Teixeira, Rogerio Saad-Hossne, Paulo Gustavo Kotze, Silvio Danese . Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery. Current Drug Targets 2019; 20(13): 1339 doi: 10.2174/1389450120666190404144048
|
| 26 |
Mattias Soop, Laura Hancock, Justin Davies. Anti-TNF Therapy Before Intestinal Surgery for Crohn’s Disease and the Risks of Postoperative Complications. Journal of Crohn's and Colitis 2021; 15(10): 1777 doi: 10.1093/ecco-jcc/jjab054
|
| 27 |
Bo Shen, Aimee Blake, Karen Lasch, Michael Smyth, Fatima Bhayat. Vedolizumab use in patients with inflammatory bowel diseases undergoing surgery: clinical trials and post-marketing experience. Gastroenterology Report 2019; 7(5): 322 doi: 10.1093/gastro/goz034
|
| 28 |
Jasmine Zanelli, Subashini Chandrapalan, Abhilasha Patel, Ramesh P. Arasaradnam. The impact of pre-operative biologic therapy on post-operative surgical outcomes in ulcerative colitis: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820937089
|
| 29 |
Takayuki Yamamoto, Takahiro Shimoyama, Satoru Umegae, Paulo Gustavo Kotze. Impact of Preoperative Nutritional Status on the Incidence Rate of Surgical Complications in Patients With Inflammatory Bowel Disease With Vs Without Preoperative Biologic Therapy: A Case-Control Study. Clinical and Translational Gastroenterology 2019; 10(6): e00050 doi: 10.14309/ctg.0000000000000050
|
| 30 |
Alaa El-Hussuna, Pär Myrelid, Stefan D Holubar, Paulo G Kotze, Graham Mackenzie, Gianluca Pellino, Des Winter, Justin Davies, Ionut Negoi, Perbinder Grewal, Gaetano Gallo, Kapil Sahnan, Ines Rubio-Perez, Daniel Clerc, Nicolas Demartines, James Glasbey, Miguel Regueiro, Ahmed E Sherif, Peter Neary, Francesco Pata, Mark Silverberg, Stefan Clermont, Sami A Chadi, Sameh Emile, Nicolas Buchs, Monica Millan, Ana Minaya-Bravo, Hossam Elfeki, Veronica De Simone, Mostafa Shalaby, Celestino Gutierrez, Cihan Ozen, Ali Yalçınkaya, David Rivadeneira, Alssandro Sturiale, Nuha Yassin, Antonino Spinelli, Jay Warusavitarne, Argyrios Ioannidis, Steven Wexner, Julio Mayol. Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future Perspectives. Crohn's & Colitis 360 2019; 1(3) doi: 10.1093/crocol/otz021
|
| 31 |
Yi Li, Weiming Zhu. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. 2018; : 273 doi: 10.1016/B978-0-12-811388-2.00024-5
|
| 32 |
Ana Gutiérrez, Montserrat Rivero, Maria Dolores Martín-Arranz, Valle García Sánchez, Manuel Castro, Jesús Barrio, Ruth de Francisco, Manuel Barreiro-de Acosta, Berta Juliá, Luis Cea-Calvo, Cristina Romero, Natalia Borruel Sainz, Eugeni Domènech. Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study. Gastroenterology Report 2019; 7(3): 168 doi: 10.1093/gastro/goz010
|
| 33 |
Angela Belvedere, Gerti Dajti, Cristina Larotonda, Laura Angelicchio, Fernando Rizzello, Paolo Gionchetti, Gilberto Poggioli, Matteo Rottoli. Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn’s Disease. Journal of Clinical Medicine 2023; 12(4): 1392 doi: 10.3390/jcm12041392
|
| 34 |
Seong-Joon Koh, Sung Noh Hong, Soo-Kyung Park, Byong Duk Ye, Kyeong Ok Kim, Jeong Eun Shin, Yong Sik Yoon, Hong Sub Lee, Sung Hoon Jung, Miyoung Choi, Soo-Young Na, Chang Hwan Choi, Joo Sung Kim. Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease. Intestinal Research 2023; 21(1): 43 doi: 10.5217/ir.2022.00029
|